A responsible read on FormBlends pillar guide starts with mechanism, side effects, access, and monitoring rather than promises. That frame keeps the discussion useful for patients without pretending the evidence is stronger than it is.
Cover image suggestion: Flat lay of a prescription vial, a syringe in original packaging, a pen, and a notepad on a wooden desk. No drug brand markings visible on the vial.
Meta description: A practical, line-by-line walkthrough of everything on a GLP-1 prescription label, from concentration and dose units to the storage codes most patients miss.
Last March, a woman named Dana in Scottsdale called her compounding pharmacy in a mild panic. She’d been prescribed tirzepatide at 2.5 mg once weekly. The vial read “10 mg/mL, 2 mL.” She loaded 25 units into her insulin syringe, thinking 2.5 mg meant 25 units. “I just wanted to make sure I wasn’t about to give myself a whole month’s worth,” she told the pharmacist. She was right to call. Twenty-five units from a 10 mg/mL vial is 2.5 mg. She had the correct dose. But the fact that she had to call at all tells you everything about how GLP-1 labels are designed: for pharmacists, not for the person standing in their kitchen holding a syringe.
The small print on these labels assumes you already understand milligrams, milliliters, units, concentrations, and storage codes. Nobody teaches you this stuff. This guide is what should come in the box but doesn’t.
Your Name, the Rx Number, and Why Both Matter More Than You Think
Start at the top of the label. Your name should match exactly. This sounds obvious until you learn that pharmacies occasionally swap labels between patients with similar names, and a GLP-1 dose calibrated for someone 80 pounds heavier than you is a genuine safety problem.
The prescription number (labeled Rx# or just Rx) is the pharmacy’s internal tracking ID. Write it down somewhere other than the bottle itself. You’ll need it when you call with a question, transfer to another pharmacy, or argue with insurance over a refill. Once you peel off the label or toss the box, that number is gone.
Drug Name, Strength, and the Math That Trips Everyone Up
This is where most confusion lives, and honestly, it’s where the label design borders on negligent.
A branded GLP-1 pen will list the generic name, the brand name, or both. Semaglutide is the generic. Ozempic and Wegovy are brand names for the same molecule at different indications and dose schedules. Tirzepatide is the generic for Mounjaro and Zepbound.
Strength gets expressed differently depending on the form factor.
Multi-dose pens usually list the total drug in the pen divided by total volume. An Ozempic 2 mg pen contains 2 mg of semaglutide in 1.5 mL of solution, roughly 1.34 mg per mL. The pen mechanism delivers four 0.5 mg doses. You don’t do any math yourself.
Compounded vials list concentration per milliliter. A vial labeled “Tirzepatide 10 mg/mL, 2 mL” contains 20 mg total drug in 2 mL of solution at 10 mg/mL. Now you’re doing the math. A 2.5 mg dose from a 5 mg/mL vial means drawing 0.5 mL, which is 50 units on a standard insulin syringe (100 units per mL, regardless of what’s inside).
Here’s the thing: the unit markings on your syringe have absolutely nothing to do with milligrams. They’re a volume measurement dressed up in confusing clothing. This is the single most common source of dosing errors I encounter, and it’s entirely a labeling and education failure.
The Sig Line: Three Things to Verify Before You Inject
The sig is the direction line, usually starting with “Inject” or “Take.” A typical GLP-1 sig reads something like: “Inject 2.5 mg subcutaneously once weekly for 4 weeks, then 5 mg once weekly.”
Check three things.
The dose. Does it match what your provider told you in your appointment? If you remember discussing 7.5 mg and the label says 5 mg, call the pharmacy before you touch a syringe.
The route. GLP-1 receptor agonists are subcutaneous, into the fat layer under the skin. Not intramuscular, not intravenous. The label will say “subQ” or “SC” or “subcutaneously.”
The frequency. Semaglutide and tirzepatide are weekly drugs. If you see “once daily” on either of these, stop. Do not inject. Call the pharmacy. The most likely explanation is a transcription error, and it’s one that could land you in the ER with severe nausea and hypoglycemia.
Quantity, Days Supply, and the Refill Clock
The quantity and days supply pair exists mostly for insurance, but it’s useful for you too.
A pen labeled “Quantity: 1, Days Supply: 28” should provide four weekly doses. If you’re finishing it in three weeks, you’re either overdosing or the pen is defective. If a vial meant for four weeks still has half its volume at week four, something’s off on the other end.
Days supply also controls your refill timing. Most insurance plans won’t authorize a refill until at least 75 percent of the days supply has passed. Try to fill a 28-day pen on day 18 and you’ll get a “refill too soon” rejection. Plan ahead for travel or supply gaps.
On refills themselves: look for the line that reads “Refills” or “Rfl.” GLP-1 prescriptions in the United States can be written for up to 12 months of refills, though many providers write three months at a time to reassess dose and side effects. If your prescription shows zero refills and you need more, do not wait until the day you run out. Most clinics need 48 to 72 hours for a refill request. Longer if labs are required.
See also: Beef Liver for Cats Explained: How It Supports Coat Health, Immunity, and Growth
Expiration Date vs. Beyond-Use Date (They’re Not the Same)
The expiration date is the manufacturer’s guarantee that the drug meets potency standards until that date. Straightforward enough.
The beyond-use date, or BUD, is a different animal entirely. It applies to compounded preparations and is assigned by the compounding pharmacy based on formulation, preservatives, storage conditions, and applicable USP standards. A compounded tirzepatide vial might carry a BUD of 28 days under refrigeration once opened, even though the underlying active ingredient has a longer shelf life. The moment you puncture the vial’s stopper, the clock starts.
If your vial carries both dates, the earlier one governs. Always.
Storage: The Fine Print That Actually Ruins Medication
The bottom of the label usually contains storage instructions in terse pharmacy shorthand. Here’s what they mean in practice:
“Store under refrigeration (2 to 8 degrees Celsius)” means the fridge, not the freezer. Freezing a GLP-1 medication denatures the peptide. The dose is destroyed. It won’t look different. It just won’t work.
“Protect from light” means keep the vial in its original carton or in a dark spot in the fridge. Not on the countertop by the window.
“Do not shake” means rotate the vial gently between your palms if mixing is needed. Aggressive shaking fragments the peptide chain, like trying to reassemble a necklace after snapping it in half.
“Discard 28 days after first use” (or similar BUD language) overrides the printed expiration once the vial is open.
A pen left out of refrigeration beyond the manufacturer’s allowed window (about 56 days for semaglutide, 21 days for tirzepatide) should be discarded even if it looks perfectly normal. Peptide degradation is invisible.
What the Label Can’t Tell You
A label won’t tell you how to titrate up. It won’t explain what to do if you miss a dose, how to manage nausea, or whether you should adjust because you’ve lost 15 pounds. Those decisions belong to your provider.
For patients who want a deeper reference on dosing schedules, compounded versus branded forms, and how to evaluate the pharmacy that filled their prescription, the FormBlends pillar guide on compounded tirzepatide covers the territory well and is updated regularly as the regulatory landscape shifts.
Five-Point Check Before Your First Injection
Before the needle touches skin, verify five things:
- Your name on the label.
- The drug name and strength.
- The dose in milligrams and the corresponding volume in milliliters (or units on your syringe).
- The expiration or beyond-use date.
- That the vial or pen has been stored correctly since it left the pharmacy.
Two minutes of label reading is the cheapest safety net in medicine. Take the time.
Frequently Asked Questions
What does “mg/mL” mean on my GLP-1 vial? It’s the concentration: how many milligrams of the active drug are dissolved in each milliliter of solution. A 10 mg/mL vial means every 1 mL contains 10 mg of the medication. You need this number to calculate how much liquid to draw for your prescribed dose.
Why do insulin syringe “units” not equal milligrams? Units on an insulin syringe are a volume measurement (100 units = 1 mL), not a drug measurement. The actual milligrams you’re injecting depend entirely on the concentration of your vial. Same syringe, different vial concentrations, wildly different doses.
Can I use my GLP-1 medication after the beyond-use date? No. The beyond-use date reflects tested stability under specific storage conditions. After that date, the compounding pharmacy cannot guarantee potency or sterility. Discard the vial and request a new one.
What should I do if the label says “once daily” for semaglutide or tirzepatide? Do not inject. Call your pharmacy immediately. Both semaglutide and tirzepatide are once-weekly medications. A “once daily” sig is almost certainly a transcription error.
How do I store my GLP-1 medication if I’m traveling? Use an insulated medication travel case with a cold pack, keeping the temperature between 2 and 8 degrees Celsius. Avoid checked luggage (cargo holds can freeze). If the medication has been out of refrigeration beyond the manufacturer’s specified window, discard it.
Is a compounded GLP-1 vial the same as a branded pen? The active ingredient may be the same molecule, but compounded medications are prepared by compounding pharmacies under different regulatory standards than FDA-approved branded products. Concentration, preservatives, and beyond-use dating will differ. The FormBlends pillar guide covers these distinctions in detail.
Compounded medications are not FDA-approved. The dosing examples in this article are illustrative and not a substitute for the specific instructions on your own prescription. Always confirm dose and storage with your prescribing clinician and pharmacist.
